Search
for
Sort by
Research 30 of 1000+
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
- DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- An overview on 5α-reductase inhibitors
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
- The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride
- A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasteride
- Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases
- Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Actions of 5α-reductase inhibitors on the epididymis
- Clinical application of 5α-reductase inhibitors
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Steroid 5α-Reductase Inhibitors
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia
- In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- 5α-Reductase inhibitors in androgenetic alopecia
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5α-reductase inhibitors
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- 5α-reductase inhibitors/finasteride